SC 13D/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under Securities Exchange Act of 1934
(Amendment No. 7)*

iKang Healthcare Group, Inc.

(Name of Issuer)

Class A Common Shares, par value US$0.01 per share**

(Title of Class of Securities)

45174L108***

(CUSIP Number)

Mr. Lee Ligang Zhang

c/o iKang Healthcare Group, Inc.

B-6F Shimao Tower, 92A Jianguo Road

Chaoyang District

Beijing 100022

People’s Republic of China

+86 10 5320 6688

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

April 6, 2018

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. o

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule §240.13d-7(b) for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

**Not for trading, but only in connection with the registration of American Depositary Shares each representing 1/2 Class A Common Share.

***This CUSIP applies to the American Depositary Shares, each representing 1/2 Class A Common Share.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 CUSIP No.  45174L108 13D/A

1	Name of Reporting Persons I.R.S. Identification Nos. of Above Persons (Entities Only) Lee Ligang Zhang
2	Check the Appropriate Box if a Member of a Group			(a) o (b)o
3	SEC Use Only
4	Source of Funds OO
5	Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)  o
6	Citizenship or Place of Organization People’s Republic of China
Number of Shares Beneficially Owned by Each Reporting Person With		7	Sole Voting Power 4,874,3711
		8	Shared Voting Power 0
		9	Sole Dispositive Power 4,874,3711
		10	Shared Dispositive Power 0
11	Aggregate Amount Beneficially Owned by Each Reporting Person 4,874,3711
12	Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares o
13	Percent of Class Represented by Amount in Row (11) 13.9%.2  The voting power of the shares beneficially owned by the Reporting Person represents 34.9% of the total outstanding voting power of all Common Shares.
14	Type of Reporting Person IN

(1)  Consists of (i) 526,721 Class A Common Shares held by Time Intelligent Finance Limited; (ii) 805,100 Class C Common Shares held by Time Intelligent Finance Limited; (iii) 2,264,140 Class A Common Shares and 1,256,820 American Depositary Shares (representing 628,410 Class A Common Shares) held by ShanghaiMed, Inc., which is wholly owned by Time Intelligent Finance Limited; (iv) 150,000 Class A Common Shares issuable upon exercise of options held by ShanghaiMed, Inc. within 60 days of the date of this Amendment No. 6; and (v) 500,000 Class A Common Shares issuable upon exercise of options held by Mr. Lee Ligang Zhang within 60 days of the date of this Amendment No. 6.

The rights of the holders of Class A and Class C Common Shares are identical, except with respect to voting and conversion rights. Each Class A Common Share will be entitled to one vote per share. Each Class C Common Share will be entitled to 15 votes per share and is convertible at any time into one Class A Common Share.

(2)  Percentage calculated based on (i) 33,572,694 Class A Common Shares (excluding Class A Common Shares issued to the depositary and reserved for exercise of options) and 805,100 Class C Common Shares outstanding as of February 28, 2018, and (ii) 150,000 Class A Common Shares issuable upon exercise of options held by ShanghaiMed, Inc. and 500,000 Class A Common Shares issuable upon exercise of options held by Mr. Lee Ligang Zhang, in each case, within 60 days of the date of this Amendment No. 6. 

2

 CUSIP No.  45174L108 13D/A

1	Name of Reporting Persons I.R.S. Identification Nos. of Above Persons (Entities Only) Time Intelligent Finance Limited
2	Check the Appropriate Box if a Member of a Group			(a) o (b)o
3	SEC Use Only
4	Source of Funds OO
5	Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)  o
6	Citizenship or Place of Organization British Virgin Islands
Number of Shares Beneficially Owned by Each Reporting Person With		7	Sole Voting Power 0
		8	Shared Voting Power 4,374,3711
		9	Sole Dispositive Power 0
		10	Shared Dispositive Power 4,374,3711
11	Aggregate Amount Beneficially Owned by Each Reporting Person 4,374,3711
12	Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares o
13	Percent of Class Represented by Amount in Row (11) 12.7%.2  The voting power of the shares beneficially owned by the Reporting Person represents 34.2% of the total outstanding voting power of all Common Shares.
14	Type of Reporting Person CO

(1)  Consists of (i) 526,721 Class A Common Shares held by Time Intelligent Finance Limited; (ii) 805,100 Class C Common Shares held by Time Intelligent Finance Limited; (iii) 2,264,140 Class A Common Shares and 1,256,820 American Depositary Shares (representing 628,410 Class A Common Shares) held by ShanghaiMed, Inc.; and (iv) 150,000 Class A Common Shares issuable upon exercise of options held by ShanghaiMed, Inc. within 60 days of the date of this Amendment No. 6. As Time Intelligent Finance Limited is wholly owned by Time Evergreen Company Limited, which in turn is wholly owned by TMF (Cayman) Ltd. as trustee of Zhang’s Family Trust with Mr. Lee Ligang Zhang as settlor, Time Intelligent Finance Limited shares the voting and dispositive power of such 4,374,371 Common Shares with Time Evergreen Company Limited and TMF (Cayman) Ltd.

(2)  Percentage calculated based on (i) 33,572,694 Class A Common Shares (excluding Class A Common Shares issued to the depositary and reserved for exercise of options) and 805,100 Class C Common Shares outstanding as of February 28, 2018, and (ii) 150,000 Class A Common Shares issuable upon exercise of options held by ShanghaiMed, Inc. within 60 days of the date of this Amendment No. 6.

3

 CUSIP No. 81783J 101 13D/A

1	Name of Reporting Persons I.R.S. Identification Nos. of Above Persons (Entities Only) ShanghaiMed, Inc.
2	Check the Appropriate Box if a Member of a Group			(a) o (b)o
3	SEC Use Only
4	Source of Funds OO
5	Check  Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)  o
6	Citizenship or Place of Organization British Virgin Islands
Number of Shares Beneficially Owned by Each Reporting Person With		7	Sole Voting Power 0
		8	Shared Voting Power 3,042,5501
		9	Sole Dispositive Power 0
		10	Shared Dispositive Power 3,042,5501
11	Aggregate Amount Beneficially Owned by Each Reporting Person 3,042,5501
12	Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares o
13	Percent of Class Represented by Amount in Row (11) 8.8%2. The voting power of the shares beneficially owned by the Reporting Person represents 6.6% of the total outstanding voting power of all Common Shares.
14	Type of Reporting Person CO

(1)  Consists of (i) 2,264,140 Class A Common Shares and 1,256,820 American Depositary Shares (representing 628,410 Class A Common Shares) held by ShanghaiMed, Inc.; and (ii) 150,000 Class A Common Shares issuable upon exercise of options held by ShanghaiMed, Inc. within 60 days of the date of this Amendment No. 6. As ShanghaiMed, Inc. is wholly owned by Time Intelligent Finance Limited, it shares the voting and dispositive power of such 3,042,550 Common Shares with Time Intelligent Finance Limited, Time Evergreen Company Limited and TMF (Cayman) Ltd. 

(2)  Percentage calculated based on (i) 33,572,694 Class A Common Shares (excluding Class A Common Shares issued to the depositary and reserved for exercise of options) and 805,100 Class C Common Shares outstanding as of February 28, 2018, and (ii) 150,000 Class A Common Shares issuable upon exercise of options held by ShanghaiMed, Inc. within 60 days of the date of this Amendment No. 6.

4

 CUSIP No. 81783J 101 13D/A

1	Name of Reporting Persons I.R.S. Identification Nos. of Above Persons (Entities Only) TMF (Cayman) Ltd. as the Trustee of Zhang’s Family Trust
2	Check the Appropriate Box if a Member of a Group			(a) o (b)o
3	SEC Use Only
4	Source of Funds OO
5	Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)  o
6	Citizenship or Place of Organization Cayman Islands
Number of Shares Beneficially Owned by Each Reporting Person With		7	Sole Voting Power 0
		8	Shared Voting Power 4,374,3711
		9	Sole Dispositive Power 0
		10	Shared Dispositive Power 4,374,3711
11	Aggregate Amount Beneficially Owned by Each Reporting Person 4,374,3711
12	Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares o
13	Percent of Class Represented by Amount in Row (11) 12.7%.2 The voting power of the shares beneficially owned by the Reporting Person represents 34.2% of the total outstanding voting power of all Common Shares.
14	Type of Reporting Person CO

(1)  Consists of (i) 526,721 Class A Common Shares held by Time Intelligent Finance Limited; (ii) 805,100 Class C Common Shares held by Time Intelligent Finance Limited; (iii) 2,264,140 Class A Common Shares and 1,256,820 American Depositary Shares (representing 628,410 Class A Common Shares) held by ShanghaiMed, Inc.; and (iv) 150,000 Class A Common Shares issuable upon exercise of options held by ShanghaiMed, Inc. within 60 days of the date of this Amendment No. 6. TMF (Cayman) Ltd. is the trustee of Zhang’s Family Trust with Mr. Lee Ligang Zhang as settlor. As TMF (Cayman) Ltd. holds all of the equity interests in Time Evergreen Company Limited which in turn holds all of the equity interests in Time Intelligent Finance Limited, TMF (Cayman) Ltd. shares the voting and dispositive power of such 4,374,371 Common Shares with Time Evergreen Company Limited and Time Intelligent Finance Limited.

(2)  Percentage calculated based on (i) 33,572,694 Class A Common Shares (excluding Class A Common Shares issued to the depositary and reserved for exercise of options) and 805,100 Class C Common Shares outstanding as of February 28, 2018, and (ii) 150,000 Class A Common Shares issuable upon exercise of options held by ShanghaiMed, Inc. within 60 days of the date of this Amendment No. 6.

5

 CUSIP No. 81783J 101 13D/A

1	Name of Reporting Persons I.R.S. Identification Nos. of Above Persons (Entities Only) Time Evergreen Company Limited
2	Check the Appropriate Box if a Member of a Group			(a) o (b)o
3	SEC Use Only
4	Source of Funds OO
5	Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e)  o
6	Citizenship or Place of Organization British Virgin Islands
Number of Shares Beneficially Owned by Each Reporting Person With		7	Sole Voting Power 0
		8	Shared Voting Power 4,374,3711
		9	Sole Dispositive Power 0
		10	Shared Dispositive Power 4,374,3711
11	Aggregate Amount Beneficially Owned by Each Reporting Person 4,374,3711
12	Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares o
13	Percent of Class Represented by Amount in Row (11) 12.7%.2  The voting power of the shares beneficially owned by the Reporting Person represents 34.2% of the total outstanding voting power of all Common Shares.
14	Type of Reporting Person CO

(1)  Consists of (i) 526,721 Class A Common Shares held by Time Intelligent Finance Limited; (ii) 805,100 Class C Common Shares held by Time Intelligent Finance Limited; (iii) 2,264,140 Class A Common Shares and 1,256,820 American Depositary Shares (representing 628,410 Class A Common Shares) held by ShanghaiMed, Inc.; and (iv) 150,000 Class A Common Shares issuable to ShanghaiMed, Inc. upon its exercise of options within 60 days of the date of this Amendment No. 6. As Time Evergreen Company Limited holds all of the equity interests in Time Intelligent Finance Limited and is wholly owned by TMF (Cayman) Ltd. as trustee of Zhang’s Family Trust with Mr. Lee Ligang Zhang as settlor, Time Evergreen Company shares the voting and dispositive power of such 4,374,371 Common Shares with Time Intelligent Finance Limited and TMF (Cayman) Ltd.

(2)  Percentage calculated based on (i) 33,572,694 Class A Common Shares (excluding Class A Common Shares issued to the depositary and reserved for exercise of options) and 805,100 Class C Common Shares outstanding as of February 28, 2018, and (ii) 150,000 Class A Common Shares issuable upon exercise of options held by ShanghaiMed, Inc. within 60 days of the date of this Amendment No. 6. 

6

Introductory Note

This Amendment No. 7 to Schedule 13D (this “Amendment No. 7”) amends and supplements the Schedule 13D filed jointly by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on September 9, 2015, as previously amended by Amendment No. 1 filed on January 5, 2016, Amendment No. 2 filed on June 7, 2016, Amendment No. 3 filed on August 25, 2017, and Amendment No. 4 filed on December 1, 2017, Amendment No. 5 filed on March 28, 2018, and Amendment No. 6 filed on March 28, 2018, respectively (the “Original Schedule 13D”). Except as amended and supplemented herein, the information set forth in the Original Schedule 13D remains unchanged. Capitalized terms used herein have meanings as assigned thereto in the Original Schedule 13D unless defined herein.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to the Securities of the Issuer

Item 6 of the Original Schedule 13D is hereby amended and supplemented by adding the following at the end thereof:

Following the repayment by ShanghaiMed Inc. (“ShanghaiMed”) of $8,000,000 due and payable under that certain facility agreement, dated August 25, 2017, by and between ShanghaiMed and Gopher Global Credit Fund II (“Gopher”), 576,230 Class A Common Shares charged in favor of Gopher pursuant to that certain equitable share mortgage, dated August 25, 2017, by and between ShanghaiMed and Gopher (as amended by a supplemental deed dated November 29, 2017) were released on April 6, 2018 pursuant to a deed of partial release dated the same date between ShanghaiMed and Gopher, which document was provided to ShanghaiMed on April 18, 2018.

Item 7.  Material to be Filed as Exhibits.

Item 7 of the Original Schedule 13D is hereby amended and supplemented by adding the following at the end thereof:

Exhibit 7.18: Deed of Partial Release, dated April 6, 2018, by and between Gopher and ShanghaiMed

* * * * *

7

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: April 24, 2018

LEE LIGANG ZHANG
By:	/s/ LEE LIGANG ZHANG
	Name: Lee Ligang Zhang
TIME INTELLIGENT FINANCE LIMITED
By:	/s/ LEE LIGANG ZHANG
	Name: Lee Ligang Zhang
	Title: Director
SHANGHAIMED, INC.
By:	/s/ LEE LIGANG ZHANG
	Name: Lee Ligang Zhang
	Title: Director
TMF (CAYMAN) LTD.
By:	/s/ YEU Chi Fai and LIU Kin Wai
	Name: YEU Chi Fai and LIU Kin Wai
	Title: Authorized Signatories
TIME EVERGREEN COMPANY LIMITED
By:	/s/ S.B. Vanwall Ltd.
	Name: S.B. Vanwall Ltd.
	Title: Director

8

INDEX TO EXHIBITS

Exhibit 7.18 Deed of Partial Release, dated April 6, 2018, by and between Gopher and ShanghaiMed

9

EX-7.18

Exhibit 7.18

This Deed of Partial Release is made the 6th day of April 2018

Between:

(1)GOPHER GLOBAL CREDIT FUND II (the “Mortgagee”); and

SHANGHAIMED, INC., a company incorporated and existing under the laws of the British Virgin Islands (registration number: 572820) with its registered office at Moore Stephens International Services (BVI) Limited, Palm Grove House, P.O. Box 3186, Wickhams Cay I, Road Town, Tortola, British Virgin Islands (the “Company”).

Whereas:

(A)Pursuant to a facility agreement dated 25 August 2017 entered into between the Company as borrower and the Mortgagee (the “Agreement”) the Mortgagee agreed to provide to the Company a US$19,000,000 term loan facility, subject to the terms and conditions set out in the Agreement.

(B)Pursuant to an equitable mortgage over shares in iKang Healthcare Group, Inc. between the Company and the Mortgagee dated 25 August 2017 (the “Share Mortgage”) the Company agreed to secure the Secured Obligations (as defined in the Share Mortgage) due, owing or payable by the Company.

(C)Following the repayment by the Company on 6 April 2018 of $8,000,000 amounts due and payable under the Agreement, the Mortgagee has agreed with the Company to release part of the security created by the Share Mortgage over and in respect of 576,230 Class A Common shares of US$0.01 par value in iKang Healthcare Group Inc.

Now this Deed witnesseth as follows:

1Partial Release

The Mortgagee hereby:

1.1acknowledges the discharge in part of the Secured Obligations;

1.2releases the security created by the Share Mortgage over and in respect of 576,230 Class A Common shares of US$0.01 par value in iKang Healthcare Group Inc. from the Share Mortgage;

1.3confirms that the Schedule to the Share Mortgage is hereby amended to record the release of the security created by the Share Mortgage over and in respect of 576,230 Class A Common shares of US$0.01 par value in iKang Healthcare Group Inc. from the Share Mortgage;

1.4delivers to the Company an executed share transfer form in respect of the shares the subject of this Deed of Partial Release; and

1.5returns to the Company share certificate(s) other than those the Mortgagee is entitled to retain pursuant to the Share Mortgage and the Agreement.

2Continuing Obligations

The Company hereby agrees and confirms that the remaining 792,317 Class A Common shares of US$0.01 par value in iKang Healthcare Group Inc are not being released, discharged or reassigned by the Mortgagee herein shall remain and stand charged to the Mortgagee under the Share Mortgage in accordance with its terms and conditions as continuing security for the due and punctual performance of the obligations of the Company under the Agreement.

3Counterparts

This Deed of Partial Release may be executed in any number of counterparts, each of which, when executed and delivered shall constitute one and the same instrument.

4Law and Jurisdiction

This Deed of Partial Release shall be governed by, and construed in accordance with, the laws of the Cayman Islands.

In witness whereof this Deed of Partial Release has been executed and delivered as Deed by the Mortgagee and the Company the day and year first above written.

EXECUTED as a DEED	)
By the Mortgagee	)
acting by Liu Hui	)	/s/ LIU HUI
	)	Director / Authorised Signatory
EXECUTED as a DEED	)
By the Company	)
acting by Ligang Zhang	)	/s/ LIGANG ZHANG
	)	Director / Authorised Signatory

2